Sterne Agee Group’s Teva Pharmaceuticals TEVA Stock Holding History

Sterne Agee Group’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$4.39M	Sell	70,250 -5,484	-7%	-$319K	0.64%	37
2014 Q4	$4.36M	Sell	75,734 -3,386	-4%	-$189K	0.68%	34
2014 Q3	$4.24M	Buy	79,120 +1,360	+2%	+$72.1K	0.67%	31
2014 Q2	$4.08M	Buy	77,760 +621	+0.8%	+$31.7K	0.68%	35
2014 Q1	$4.08M	Buy	77,139 +64,929	+532%	+$3M	0.8%	26
2013 Q4	$489K	Buy	+12,210	New	+$481K	0.16%	157

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Sterne Agee Group's TEVA Position: Q1 2015 in Review

Sterne Agee Group reduced its Teva Pharmaceuticals (TEVA) stake by 7.2% in Q1 2015, selling an estimated $319K and leaving 70,250 shares worth $4.39M. The position accounts for 0.64% of the portfolio, ranked #37.

Sterne Agee Group first reported a position in TEVA in Q4 2013 and has held it in 6 quarters since. 821 funds tracked by Wall St. Rank hold TEVA as of Q1 2015.

Sterne Agee Group held 70,250 shares of Teva Pharmaceuticals worth $4.39M as of Q1 2015.
Sterne Agee Group sold 5,484 Teva Pharmaceuticals shares in Q1 2015, an estimated $319K.
Teva Pharmaceuticals made up 0.64% of Sterne Agee Group's portfolio in Q1 2015, its #37 holding.
Sterne Agee Group first reported a position in Teva Pharmaceuticals in Q4 2013 and has held it in 6 quarters since.
821 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2015.

Based on Sterne Agee Group's 13F filing for Q1 2015, filed 13 May 2015.